Palantir Technologies Stock Quote PLTR - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

64.65

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

147.209B

Previous Close

64.65

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

2,277,016,000

Dividend Yield

PE Ratio

701.95

Earnings Per Share (EPS)

0.09

Revenue

2.23B

Net Profit

209.83M

Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Pal... Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers. Show more

Sector

Prepackaged Software

Industry

Prepackaged Software

Website

www.palantir.com.

Headquarters

Wilmington, Delaware, USA

Founded

U.S. National Institutes of Health Recommend to Expand Its Scope of Research in the Development of Pluristem's PLX-RAD Cells fo

HAIFA, Israel, July 18, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the U.S...

Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial

HAIFA, Israel, July 11, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today it has completed the...

Pluristem's South Korean Partner Files IND With Korean FDA for PLX Cells

HAIFA, Israel, July 8, 2013 (GLOBE NEWSWIRE) -- On the heels of announcing its strategic partnership agreement with Cha Bio&Diostech (Kosdaq:CHA) on June 26th, Pluristem Therapeutics Inc...

Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercializa

HAIFA, Israel, June 26, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) today announced that its wholly owned subsidiary, Pluristem Ltd., has entered into an...

Pluristem's Preclinical Results for Its PLX-RAD Cells Published in the Journal PLOS ONE

HAIFA, Israel, June 20, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that preclinical...

Pluristem Provides Update on Clinical Status of IC Trials

HAIFA, Israel, June 19, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, provided an update today on the...

Pluristem to Deliver Two Presentations During Israel's Largest Biotech Conference: IATI-BioMed

HAIFA, Israel, June 10, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that Pluristem's CEO...

Pluristem to Receive Clinical-hold Notice From the U.S. FDA

HAIFA, Israel, June 4, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that it has received...

Pluristem to Present at FDA Symposium

HAIFA, Israel, May 29, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the company has...

Pluristem Welcomes Parliamentary State Secretary of the German Federal Ministry for Environmental, Nature Conservation and Nucl

HAIFA, Israel, May 22, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that Katherina Reiche...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

PLTR - Frequently Asked Questions (FAQ)

What is the current Palantir Technologies share price?

The current share price of Palantir Technologies is $ 64.65

How many Palantir Technologies shares are in issue?

Palantir Technologies has 2,277,016,000 shares in issue

What is the market cap of Palantir Technologies?

The market capitalisation of Palantir Technologies is USD 147.21B

What is the 1 year trading range for Palantir Technologies share price?

Palantir Technologies has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Palantir Technologies?

The price to earnings ratio of Palantir Technologies is 701.95

What is the cash to sales ratio of Palantir Technologies?

The cash to sales ratio of Palantir Technologies is 66.16

What is the reporting currency for Palantir Technologies?

Palantir Technologies reports financial results in USD

What is the latest annual turnover for Palantir Technologies?

The latest annual turnover of Palantir Technologies is USD 2.23B

What is the latest annual profit for Palantir Technologies?

The latest annual profit of Palantir Technologies is USD 209.83M

What is the registered address of Palantir Technologies?

The registered address for Palantir Technologies is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Palantir Technologies website address?

The website address for Palantir Technologies is www.palantir.com.

Which industry sector does Palantir Technologies operate in?

Palantir Technologies operates in the PREPACKAGED SOFTWARE sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BOEBlackRock Enhanced Global Dividend Trust	$ 16.50 (52.50%)	3
BXMXNuveen S&P 500 Buy Write Income Fund	$ 16.99 (24.01%)	38
NFJVirtus Dividend Interest and Premium Strategy Fund	$ 14.99 (21.57%)	2
ASIXAdvanSix Inc	$ 33.99 (18.35%)	24
CAAPCorporacion America Airports SA	$ 21.99 (16.66%)	11
ETBEaton Vance Tax Managed Buy Write Income Fund	$ 12.01 (-19.61%)	1
MUIBlackRock Municipal Income Fund Inc	$ 10.01 (-19.21%)	1
LWLamb Weston Holdings Inc	$ 64.00 (-18.18%)	27k
WEAWestern Asset Premier Bond Fund	$ 9.01 (-16.34%)	2
MVFBlackRock MuniVest Fund Inc	$ 6.01 (-15.59%)	1
QBTSD Wave Quantum Inc	$ 9.20 (2.68%)	2.12M
IONQIonQ Inc	$ 39.44 (5.17%)	893.18k
BBAIBigBear ai Holdings Inc	$ 3.39 (8.31%)	747.24k
ACHRArcher Aviation Inc	$ 9.36 (4.58%)	566.62k
JOBYJoby Aviation Inc	$ 8.11 (2.14%)	435k